Skip to content

Team-Focused Implementation in Child Advocacy Centers

Implementation of the Care Process Model for Pediatric Traumatic Stress in Rural Child Advocacy Centers: A Pilot Test of Team-focused Implementation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05679154
Enrollment
147
Registered
2023-01-10
Start date
2024-07-31
Completion date
2025-10-08
Last updated
2026-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health Issue, Teamwork

Keywords

Mental health screening, Implementation, Teamwork

Brief summary

Child Advocacy Centers (CACs) are well-positioned to identify children at risk for mental health problems and to facilitate access to evidence-based treatments. Implementation of standardized mental health screening and referral protocols may improve recognition of mental health needs and facilitate treatment engagement. Implementation strategies that improve teamwork may enhance implementation outcomes in team-based settings like CACs. In this study, CACs will implement the Care Process Model for Pediatric Traumatic Stress (CPM-PTS) and be randomized to either team-focused implementation or standard implementation. The study aims are to evaluate the feasibility of team-focused implementation and the effect of the CPM-PTS on caregiver understanding of mental health needs and intentions to initiate treatment.

Detailed description

This study is a pilot cluster randomized controlled hybrid Type II effectiveness-implementation trial in 4 rural Child Advocacy Centers. All CACs will implement the Care Process Model for Pediatric Traumatic Stress (CPM-PTS), a mental health screening and referral protocol. CACs will be randomized to team-focused implementation (n = 2) or standard implementation (n = 2). The study is designed to evaluate the acceptability, appropriateness, and feasibility of team-focused implementation strategies. It will also test the effect of the CPM-PTS on caregiver understanding of mental health needs and intentions to initiate treatment. Mixed methods will be used to evaluate the feasibility of team-focused implementation, test the effect of team strategies on teamwork, and assess implementation outcomes. Administrative data collected anonymously from caregivers will be used to test the effectiveness of the CPM-PTS.

Interventions

BEHAVIORALTeam-focused Implementation

CACs randomized to the experimental condition (n = 2) will participate in team-focused implementation. They will receive team development interventions (e.g., goal-setting exercise, training in communication skills) integrated with standard CPM-PTS training and technical assistance strategies.

CACs randomized to the comparison condition (n = 2) will receive standard training and technical assistance strategies to support CPM-PTS implementation. They will receive CPM-PTS materials (e.g., manual, REDCap surveys, referral protocols), an interactive training, and six months of technical assistance.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

The trial includes two groups: team-focused implementation and standard implementation (comparison group).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals at least 18 years of age who are members of the multidisciplinary team at the participating CACs.

Exclusion criteria

* Under 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Team-focused Implementation Assessed by the Acceptability of Intervention MeasureMonth 6Perceived acceptability of team-focused implementation will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).
Appropriateness of Team-focused Implementation Assessed by the Intervention Appropriateness MeasureMonth 6Perceived appropriateness of team-focused implementation will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).
Feasibility of Team-focused Implementation Assessed by the Feasibility of Intervention MeasureMonth 6Perceived feasibility of team-focused implementation will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).

Secondary

MeasureTime frameDescription
Change in Team Functioning (Learning Behavior) From Baseline to 6-month Follow-upBaseline, month 6Affective, behavioral, and cognitive processes and states will be assessed with survey items rated on Likert scales. Scores will be averaged; higher scores indicate more adaptive team functioning (range 1-7). Learning behavior was assessed with 3 items.
Change in Team Functioning (Learning Behavior) From Baseline to 12-month Follow-upBaseline, month 12Affective, behavioral, and cognitive processes and states will be assessed with survey items rated on Likert scales. Scores will be averaged; higher scores indicate more adaptive team functioning (range 1-7). Learning behavior was assessed with 3 items.
Change in Team Performance From Baseline to 6- and 12-month Follow-upBaseline, month 6, month 12The overall quality of work done by the team will be assessed with 4 items rated on a 5-point Likert scale. Scores will be averaged; higher scores indicate better performance (range 1-5).
CPM-PTS Acceptability Assessed by the Acceptability of Intervention MeasureMonth 6Perceived acceptability of the CPM-PTS will be assessed with items from the Acceptability of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).
CPM-PTS Appropriateness Assessed by the Intervention Appropriateness MeasureMonth 6Perceived appropriateness of the CPM-PTS will be assessed with items from the Intervention Appropriateness Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).
CPM-PTS Feasibility Assessed by the Feasibility of Intervention MeasureMonth 6Perceived feasibility of the CPM-PTS will be assessed with items from the Feasibility of Intervention Measure. Each item is rated on a 1-5 Likert scale. Scores will be averaged; higher scores indicate more positive perceptions (range 1-5).
CPM-PTS AdoptionFrom start of the study for up to 12 months after CPM-PTS implementationAdoption will be indicated by the number of days from training to the first completed screening.
CPM-PTS ReachMonthly for 9 months after CPM-PTS implementationReach will be indicated by screening rates (i.e., completed screenings / eligible children) and calculated for monthly and quarterly periods (possible range 0-100%). Reported below are the average monthly screening rate over 9 months (all available data) and the average quarterly screening rate across 3 quarters (all available data).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORElizabeth McGuier, PhD

University of Pittsburgh

Participant flow

Recruitment details

Only current team members were eligible to participate at each timepoint. Participants who joined the team after the study began were invited to participate in data collection for later timepoints. Participants who left the team before a follow-up timepoint were not invited to participate in additional data collection.

Pre-assignment details

One center withdrew from the study during baseline data collection and before randomization. Participants affiliated with this center (n = 55) did not participate in any additional data collection. Outcome measures are not available for these participants. No caregivers were enrolled in this study.

Baseline characteristics

Characteristic—
Age, Continuous42.81 Years
STANDARD_DEVIATION 12.69
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
47 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
18 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
18 Participants
Race (NIH/OMB)
White
51 Participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 550 / 37
other
Total, other adverse events
0 / 550 / 37
serious
Total, serious adverse events
0 / 550 / 37

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 7, 2026